| DB ID | MyCo_7157 |
| Title | Biomarker-guided antifungal therapy in patients with suspected invasive candidiasis: Ready for prime time? |
| Year | 2017 |
| PMID | 29119220 |
| Fungal Diseases involved | Invasive candidiasis |
| Disease | Candidiasis (Candida Infection) |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | spp. |
| Organism | Candida spp. |
| Ethical Statement | None |
| Site of Infection | Unspecified |
| Opportunistic invasive | Invasive |
| Sample type | None |
| Sample source | NA |
| Host Group | NA |
| Host Common name | NA |
| Host Scientific name | NA |
| Biomarker Name | BDG |
| Biomarker Full Name | 1-3-beta-D-Glucan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Multi-Location |
| Cohort | None |
| Cohort No. | None |
| Age Group | None |
| P Value | None |
| Sensitivity | 0.767 |
| Specificity | 0.572 |
| Positive Predictive Value | 0.217 |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | ELISA |
| Technique | Immunoassay |
| Analysis Method | Fungitell kit |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | None |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
